Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Myelodysplastic Syndromes 48Leukemia 35Lymphoma 24Leukemia, Lymphocytic, Chronic, B-Cell 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Lymphoma, Non-Hodgkin 21Hodgkin Disease 21Multiple Myeloma 18Hematologic Neoplasms 18Leukemia, Myelomonocytic, Chronic 11Leukemia, Biphenotypic, Acute 9Graft vs Host Disease 9Myeloproliferative Disorders 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Juvenile 7Neoplasms, Plasma Cell 6Lymphoma, Follicular 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Accelerated Phase 4Hemoglobinuria, Paroxysmal 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4Recurrence 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

fludarabine 6Tacrolimus 6Busulfan 6blinatumomab 5Rituximab 5Cyclophosphamide 5fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Epoetin Alfa 4venetoclax 3Whole-Body Irradiation 3Methotrexate 3Darbepoetin alfa 3Alemtuzumab 3ponatinib 2ibrutinib 2entrectinib 2alectinib 2Thiotepa 2Therapeutics 2Patient Reported Outcome Measures 2Mesna 2Melphalan 2Everolimus 2Early Intervention, Educational 2Bone Marrow Transplantation 2Antilymphocyte Serum 2vandetanib 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoproliferative Disorders × Stem Cell Transplantation × Other hematologic neoplasm × Clear all
NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡